Sarah Shapley received a B.S. in Neuroscience and Biology from Baldwin Wallace University. She defended her senior thesis on investigating the role of citrullination during central nervous system myelination. Throughout undergraduate studies, Sarah engaged in additional fellowship opportunities, including developing a pipeline to create preclinical models of Late-Onset Alzheimer’s Disease at the Jackson Laboratory (2018) and studying Epstein-Barr virus immunoreactivity of active and stable multiple sclerosis patients at the National Institutes of Health (2019). Sarah is currently a Ph.D. student in Emory’s Neuroscience program and joined the Seyfried laboratory in 2021, where she investigates factors perpetuating tau aggregation in neurodegenerative disorders.